-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GoSqIJWNm8fw3Rm7JCuUENjPBt2qYnvQzob4ekt9bESK2NiaDypaOodeUyml00eh KfY4O/s6UGccJ+sBUeU57g== 0000950134-07-011569.txt : 20070515 0000950134-07-011569.hdr.sgml : 20070515 20070515121601 ACCESSION NUMBER: 0000950134-07-011569 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070515 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070515 DATE AS OF CHANGE: 20070515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN SHARED HOSPITAL SERVICES CENTRAL INDEX KEY: 0000744825 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 942918118 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08789 FILM NUMBER: 07850775 BUSINESS ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 BUSINESS PHONE: 415-788-5300 MAIL ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 8-K 1 f30389e8vk.htm FORM 8-K e8vk
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported) May 15, 2007
AMERICAN SHARED HOSPITAL SERVICES
(Exact name of registrant as specified in its chapter)
         
California
(State or other jurisdiction
of incorporation)
  1-08789
(Commission
File Number)
  94-2918118
(IRS Employer
Identification No.)
     
Four Embarcadero Center, Suite 3700, San Francisco, CA
(Address of principal executive offices)
  94111
(Zip Code)
Registrant’s telephone number, including area code 415-788-5300
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

ITEM 2.02   RESULTS OF OPERATIONS AND FINANCIAL CONDITIONS
On May 15, 2007, the Company issued a press release announcing its financial results for the three months ended March 31, 2007. The full text of the press release is attached hereto as Exhibit 99.1. The Company does not intend for this exhibit to be incorporated by reference into future filings under the Securities Exchange Act of 1934. The foregoing information is provided pursuant to Item 12 (Results of Operations and Financial Condition) of Form 8-K.
ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS
          (a)         Not applicable.
          (b)         Not applicable.
          (c)         Exhibits
          The following exhibit is filed as part of this report:
          99.1       Earnings Press Release, dated 5/15/07

 


 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: May 15, 2007   American Shared Hospital Services
 
 
  By:   /s/ Ernest A. Bates, M.D.    
    Ernest A. Bates, M.D.   
    Chairman and CEO   
 

 

EX-99.1 2 f30389exv99w1.htm EXHIBIT 99.1 exv99w1
 

Exhibit 99.1
AMERICAN SHARED HOSPITAL SERVICES
REPORTS FIRST QUARTER RESULTS
 
San Francisco, CA, May 14, 2007 — AMERICAN SHARED HOSPITAL SERVICES (AMEX:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the first quarter of 2007.
First Quarter Results
For the three months ended March 31, 2007, revenue decreased to $4,749,000 from $5,045,000 as patient volume for this year’s first quarter was below the record volume experience in last year’s first quarter. This primarily reflected downtime required for cobalt reload at one of the Company’s centers and personnel shortages at another center. The reload has been completed and the staffing issues have been resolved, and these issues are not expected to affect patient volume in the current quarter. Gross margin was 47% for this year’s first quarter versus 48% for the prior year.
Selling and administrative expenses increased to $1,161,000 for the first quarter of 2007 compared to $914,000 for the first quarter of 2006. A significant part of this increase is related to the Company’s development of its proton beam radiation therapy (PBRT) business.
Operating income for the first quarter of 2007 decreased to $602,000 compared to $946,000 for the first quarter of 2006. Net income for the three months ended March 31, 2007 was $225,000, or $0.04 per diluted share. This compares to net income for the three months ended March 31, 2006 of $436,000, or $0.09 per diluted share.
At March 31, 2007, AMS reported cash, cash equivalents, and short and long-term securities of $8,916,000. At December 31, 2006, AMS reported cash, cash equivalents and short and long-term securities of $8,906,000. Shareholders’ equity at March 31, 2007 was $19,010,000 compared to $19,009,000 at December 31, 2006.
Chairman and Chief Executive Officer Ernest A. Bates, M.D., said, “We are devoting the management resources and marketing dollars required to build the foundation for sustained long-term growth. We are committed to our strategy to leverage AMS’ creative financing solutions by offering our clinical partners the latest technology solutions for radiation oncology delivery. We currently are developing additional agreements to provide clients with advanced radiation therapy devices as part of a radiation therapy department upgrade, including additional PBRT systems, Leksell Gamma Knife Perfexion™ systems, and other radiosurgery devices.
“We continue to expect our agreement with Tufts-NEMC to provide an image-guided radiation therapy (IGRT) system, a CT Simulator, and related service, support and maintenance services to contribute to our operating results beginning in the fourth quarter, and to begin upgrading clinical partner sites later this year with the four Leksell Gamma Knife Perfexion systems we ordered from Elekta AB in 2006. We also expect to commence our lease agreements with Tufts-NEMC and M. D. Anderson Cancer Center Orlando for the Clinatron 250™ PBRT system in 2009, subject to FDA approval.”

 


 

The Clinatron 250, currently under development by Still River Systems, is a single-treatment-room PBRT system incorporating proprietary technology that Still River believes may dramatically reduce the cost of implementing proton beam radiation therapy. In April 2006, AMS invested $2 million for an equity interest in Still River Systems and acquired an option to purchase two PBRT systems. AMS exercised this purchase option in February 2007.
Earnings Conference Call
American Shared has scheduled a conference call at 1:00 p.m. PT (4:00 p.m. ET) today. To participate in the live call, dial (800) 588-4973 at least 5 minutes prior to the scheduled start time. A simultaneous WebCast of the call may be accessed through the Company’s website, www.ashs.com, or through CCBN, www.earnings.com (individual investors) or www.streetevents.com (institutional investors). A replay will be available for 30 days at these same internet addresses, or by calling (888) 843-8996, pass code 17904583.
About AMS
American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery services, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st Century concept. Through its equity investment in Still River Systems, AMS also plans to complement these services with the Clinatron 250™ proton beam radiation therapy (PBRT) system, which has not yet been approved by the FDA.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife business, the risks of developing its IMRT and The Operating Room for the 21st Century® programs, and the risks of investing in a development-stage company, Still River Systems, Inc., without a proven product. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2006, and the definitive Proxy Statement for the Annual Meeting of Shareholders to be held on June 14, 2007.
     
Contacts:
  American Shared Hospital Services
 
  Ernest A. Bates, M.D., (415) 788-5300
 
  Chairman and Chief Executive Officer
 
  e.bates@ashs.com
 
   
 
  Berkman Associates
 
  Neil Berkman, (310) 826-5051
 
  President
 
  info@berkmanassociates.com

 


 

AMERICAN SHARED HOSPITAL SERVICES
     
PRESS RELEASE
  May 15, 2007
First Quarter 2007 Financial Results
  Page 3
Selected Financial Data
(unaudited)
                 
       
       
    Summary of Operations Data  
       
    Three months ended March 31,  
    2007     2006  
Revenue
  $ 4,749,000     $ 5,045,000  
Costs of revenue
    2,519,000       2,622,000  
 
           
Gross margin
    2,230,000       2,423,000  
Selling & administrative expense
    1,161,000       914,000  
Interest expense
    467,000       563,000  
 
           
Operating income
    602,000       946,000  
Interest & other income
    118,000       90,000  
Minority interest expense
    (300,000 )     (316,000 )
 
           
Income before income taxes
    420,000       720,000  
Income tax expense
    195,000       284,000  
 
           
Net income
  $ 225,000     $ 436,000  
 
           
 
               
Earnings per common share:
               
Basic
  $ 0.04     $ 0.09  
 
           
Assuming dilution
  $ 0.04     $ 0.09  
 
           
 
               
    Balance Sheet Data
 
               
 
    3/31/2007       3/31/2006  
 
           
Cash and cash equivalents
  $ 3,221,000     $ 1,166,000  
Securities-current maturities
  $ 1,900,000     $ 6,663,000  
Current assets
  $ 10,726,000     $ 12,988,000  
Securities-long term
  $ 3,795,000     $ 601,000  
Total assets
  $ 50,651,000     $ 49,080,000  
 
               
Current liabilities
  $ 11,833,000     $ 8,210,000  
Shareholders’ equity
  $ 19,010,000     $ 18,526,000  

-----END PRIVACY-ENHANCED MESSAGE-----